このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Terumo マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Hikaru Samejima

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	less than a year
CEOの所有権	n/a
経営陣の平均在職期間	less than a year
取締役会の平均在任期間	4.5yrs

経営陣の近況

Recent updates

CEO（最高経営責任者

Hikaru Samejima (60 yo)

less than a year

在職期間

Mr. Hikaru Samejima serves as Director of Terumo Corporation since February 7, 2024. He serves as President and CEO of Terumo Corporation since April 1, 2024. He served as Group Senior Managing Executive O...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Shinjiro Sato	Corporate Advisor & Director	less than a year	JP¥169.00m	0.0099% ¥ 382.6m
Hikaru Samejima	President	less than a year	データなし	データなし
Jin Hagimoto	CFO, CIO	less than a year	データなし	データなし
Shinji Omori	CTO, GM of DX Promotion Dept. R&D Division and Executive Officer	less than a year	データなし	データなし
Miho Mizuguchi	Executive Officer	8.2yrs	データなし	データなし
Tomoko Adachi	Chief Human Resources Officer & Group Executive Officer	1.4yrs	データなし	データなし
Shoji Hatano	Director & Corporate Advisor	less than a year	データなし	0.0035% ¥ 135.9m
James Rushworth	Group Executive Officer & Chief Commercial Officer	1.4yrs	データなし	データなし
Kazunori Hirose	Director & Group Managing Executive Officer	no data	データなし	0.0018% ¥ 69.7m
Itaru Sakaguchi	Group Managing Executive Officer	less than a year	データなし	データなし
Toshihiko Osada	Group Senior Managing Executive Officer	no data	データなし	データなし
Fumihisa Hirose	Group Managing Executive Officer	less than a year	データなし	データなし

0.4yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: 4543の経営陣は経験豊富とはみなされません ( 0.4年の平均在職年数)。これは新しいチームを示唆しています。

取締役

名称	ポジション	在職期間	報酬	所有権
Shinjiro Sato	Corporate Advisor & Director	10yrs	JP¥169.00m	0.0099% ¥ 382.6m
Hikaru Samejima	President	less than a year	データなし	データなし
Shoji Hatano	Director & Corporate Advisor	8yrs	データなし	0.0035% ¥ 135.9m
Kazunori Hirose	Director & Group Managing Executive Officer	2.4yrs	データなし	0.0018% ¥ 69.7m
Norimasa Kunimoto	Director & Group Managing Executive Officer	less than a year	データなし	0.0021% ¥ 81.2m
Soichiro Uno	Independent Outside Director	5yrs	データなし	データなし
Hidenori Nishi	Independent Outside Director	4yrs	データなし	0.00022% ¥ 8.5m
Yukiko Kuroda	Independent Outside Director	6yrs	データなし	0.00010% ¥ 3.8m
Takanori Shibazaki	Director	3yrs	データなし	0.0023% ¥ 88.1m
Toshiaki Takagi	Chairman of the Board & Group Managing Executive Officer	14yrs	JP¥131.00m	データなし
Masaichi Nakamura	Independent Outside Director	5yrs	データなし	0.00027% ¥ 10.4m
Keiya Ozawa	Independent Outside Director	3yrs	データなし	0.000070% ¥ 2.7m

4.5yrs

平均在職期間

63.5yo

平均年齢

経験豊富なボード: 4543の取締役会は経験豊富であると考えられます ( 4.5年の平均在任期間)。

Terumo マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Recent updates

Return Trends At Terumo (TSE:4543) Aren't Appealing

Now 20% overvalued

Terumo Corporation to Report Q1, 2025 Results on Aug 08, 2024

Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview™? Monitoring System

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 10% to JP¥3,255

Calculating The Fair Value Of Terumo Corporation (TSE:4543)

Investors Still Waiting For A Pull Back In Terumo Corporation (TSE:4543)

Consensus EPS estimates increase by 11%

Price target increased by 7.4% to JP¥3,136

Terumo (TSE:4543) Has Announced A Dividend Of ¥22.00

New minor risk - Dividend sustainability

Upcoming dividend of JP¥22.00 per share

Terumo Corporation to Report Fiscal Year 2024 Results on May 14, 2024

Is Terumo (TSE:4543) Using Too Much Debt?

Price target increased by 7.3% to JP¥5,548

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024

Terumo Corporation, Annual General Meeting, Jun 26, 2024

Terumo Corporation to Report Q3, 2024 Results on Feb 07, 2024

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation to Report Q2, 2024 Results on Nov 14, 2023

Upcoming dividend of JP¥22.00 per share at 1.1% yield

Terumo Corporation (TSE:4543) announces an Equity Buyback for 5,000,000 shares, representing 0.67% for ¥20,000 million.

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation to Report Q1, 2024 Results on Aug 09, 2023

Terumo Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2023, Payable on June 28, 2023; Provides Second Quarter-End Dividend Guidance for the Fiscal Year Ending March 31, 2024 and Provides Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 27, 2023

Upcoming dividend of JP¥21.00 per share at 1.2% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

Less than half of directors are independent

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Terumo Corporation Announces Dividend for the Second Quarter End of Fiscal Year 2023, Commences Dividend Payments on December 5, 2022; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Terumo Corporation to Report Q3, 2023 Results on Nov 10, 2023

Terumo Corporation to Report Q2, 2023 Results on Nov 10, 2022

Upcoming dividend of JP¥18.00 per share

Mitsui DM Sugar Holdings Co.,Ltd. (TSE:2109) agreed to acquire Enteral formula business of Terumo Corporation from Terumo Corporation (TSE:4543).

NUTRI Co.,Ltd. entered into an agreement to acquire Nutritional food and related product assets of Terumo Corporation.

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Terumo Corporation Provides Dividend Guidance for the Second Quarter of Year Ending March 31, 2023

Less than half of directors are independent

Terumo Announces Change in Indication for Dexcom G6 CGM System in Japan

Full year 2022 earnings: EPS misses analyst expectations

Terumo Corporation (TSE:4543) announces an Equity Buyback for 15,000,000 shares, representing 1.98% for ¥50,000 million.

Less than half of directors are independent

Terumo Corporation to Report Fiscal Year 2022 Results on May 12, 2022

Upcoming dividend of JP¥16.00 per share

Third quarter 2022 earnings: EPS misses analyst expectations

Terumo Corporation, Annual General Meeting, Jun 22, 2022

Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥29.22 (vs JP¥23.63 in 2Q 2021)

Upcoming dividend of JP¥15.00 per share

First quarter 2022 earnings released: EPS JP¥36.90 (vs JP¥18.57 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Full year 2021 earnings released: EPS JP¥102 (vs JP¥114 in FY 2020)

Terumo Corporation Provides Dividend Guidance for the Year Ending March 2022

Upcoming dividend of JP¥14.00 per share

New 90-day low: JP¥3,951

Terumo Corporation (TSE:4543) signed definitive agreement to acquire All Assets from Health Outcomes Sciences, Inc.

Terumo Corporation Announces Clinical Study in Japan for Product Using Terumo's Automated Injection Device Developed in Collaboration with Kyowa Kirin Co., Ltd

New 90-day high: JP¥4,560

Terumo Corporation Revises Earnings Guidance for the Fourth Quarter of Fiscal 2021

Third quarter 2021 earnings released: EPS JP¥35.40 (vs JP¥28.22 in 3Q 2020)

Revenue and earnings beat expectations

IceCure Medical Ltd Inks Expanded Distribution Agreement with Terumo Corporation for Thailand

Terumo Corporation to Report Q3, 2021 Results on Feb 04, 2021

マネジメント基準チェック /14